Calgary, Alberta, September 4, 2025 – TheNewswire - Universal Ibogaine Inc. (TSXV: IBO, in USA: IBOGF, in Germany FSE:JC4) (“ UI ” or the “ Company ) is pleased to announce its intention to file, within 90 days, an application to Health Canada to initiate clinical trials (the Clinical Trial Application, or “ CTA ”) with the aim of investigating Ibogaine as a promising treatment for addiction for opioid use disorder(s) (the “... Read More

Calgary, AB – September 3, 2025 – TheNewswire - Universal Ibogaine Inc. ( TSXV:IBO ) (“ UI ” or the “ Company ”), a life sciences company with a mission to research and deliver medicalized ibogaine-centered addiction care, advises that the existing Board of Directors of the Company (the “ Board ”) appointed two new Directors to join the Board, effective August 28, 2025, with one of the Board members filling a vacant Board... Read More

Calgary, AB – TheNewswire - July 16, 2025 – Universal Ibogaine Inc. ( TSXV:IBO ) (“ UI ” or the “ Company ”), a life sciences company with a mission to research and deliver medicalized ibogaine-centered addiction care, advises that Greg Leavens has resigned from his role as Chief Financial Officer and Corporate Secretary of the Company in order to pursue other opportunities. Nick Karos, CEO and Director, noted “On behalf of... Read More

Calgary, AB – TheNewswire - J uly 7, 2025 – Universal Ibogaine Inc . ( TSXV:IBO ) (“ UI ” or the “ Company ”), a life sciences company with a mission to research and deliver medicalized ibogaine-centered addiction care, advises that Ken Cranwill has resigned from the Board of Directors of the Company in order to focus on his other business ventures. Nick Karos, CEO and Director, noted “On behalf of the Board of Directors,... Read More

Calgary, AB – TheNewswire - April 3, 2025 – Universal Ibogaine Inc. ( TSXV:IBO ) (“ UI ” or the “ Company ”), a life sciences company with a mission to deliver medicalized ibogaine-centered addiction care, advises that it has agreed to settle a portion, totalling $106,200, of arrears consulting fees owed to its CEO, Nicholas Karos (the “ Debt ”). UI is in process of applying to the TSX Venture Exchange (the “ TSXV ”) to... Read More

Calgary, AB – TheNewswire - January 27, 2025 – Universal Ibogaine Inc. ( TSXV:IBO ) (“ UI ” or the “ Company ”), a life sciences company with a mission to deliver medicalized ibogaine-centered addiction care, provides the following bi-weekly default status report update: Management Cease Trade Order (“MCTO”) Further to the Company’s prior news releases (dated November 18, November 26, December 11, and December 27, 2024 and... Read More

Calgary, AB – January 22, 2025 – TheNewswire - Universal Ibogaine Inc. ( TSXV:IBO ) (“ UI ” or the “ Company ”), a life sciences company with a mission to deliver medicalized ibogaine-centered addiction care, is pleased to advise it has closed the sale of its Belize Property. As previously announced (see prior News Releases dated November 26, December 11, and December 27, 2024 and January 13, 2025) the Company agreed to sell... Read More

Calgary, AB – January 13, 2025 – TheNewswire - Universal Ibogaine Inc. ( TSXV:IBO ) (“ UI ” or the “ Company ”), a life sciences company with a mission to deliver medicalized ibogaine-centered addiction care, provides the following bi-weekly default status report update: Management Cease Trade Order (“MCTO”) Further to the Company’s prior news releases (dated November 18, November 26, December 11 and December 27, 2024), t he... Read More

Calgary, AB – TheNewswire - December 27, 2024 – Universal Ibogaine Inc. ( TSXV:IBO ) (“ UI ” or the “ Company ”), a life sciences company with a mission to deliver medicalized ibogaine-centered addiction care, provides the following bi-weekly default status report update: Management Cease Trade Order (“MCTO”) Further to the Company’s prior news releases (November 18, 26 and December 11, 2024), t he Company is providing this... Read More

Calgary, AB – TheNewswire - December 11, 2024 – Universal Ibogaine Inc. ( TSXV:IBO ) (“ UI ” or the “ Company ”), a life sciences company with a mission to deliver medicalized ibogaine-centered addiction care, provides the following bi-weekly default status report update: Management Cease Trade Order (“MCTO”) Further to the Company’s prior news releases (November 18 and November 26, 2024), t he Company is providing this... Read More

Calgary, AB – TheNewswire - November 26, 2024 – Universal Ibogaine Inc. ( TSXV:IBO ) (“ UI ” or the “ Company ”), a life sciences company with a mission to research and deliver medicalized ibogaine-centered addiction care, is pleased to advise that it has received an offer to purchase (the “ Offer ”) its undeveloped 20-acre island property in Belize (the “ Property ”) for USD 300,000. The Offer is to purchase the shares of... Read More

Calgary, AB – TheNewswire - June 7, 2024 – Universal Ibogaine Inc. ( TSXV:IBO ) (“ UI ” or the “ Company ”), a life sciences company with a mission to research and deliver medicalized ibogaine-centered addiction care, advises that it has closed its previously announced (see News Release of April 12) non-brokered private placement offering of common shares (the “ Offering ”) and has issued a total of 13,500,000 common shares... Read More

Calgary, AB – TheNewswire - April 29, 2024 – Universal Ibogaine Inc. ( TSXV:IBO ) (“ UI ” or the “ Company ”), a life sciences company with a mission to research and deliver medicalized ibogaine-centered addiction care, is pleased to provide an update on its planned Clinical Trial Application (“ CTA ”) process. UI has engaged a new clinical research organization (“ CRO ”) to complete the process of compiling UI’s submission... Read More

Calgary, AB – TheNewswire - April 22, 2024 – Universal Ibogaine Inc. ( TSXV:IBO ) (“ UI ” or the “ Company ”), a life sciences company with a mission to research and deliver medicalized ibogaine-centered addiction care, advises that it intends to undertake a non-brokered private placement offering of up to 23,333,333 common shares at a price of $0.015 per share, for proceeds of up to $350,000 (the “ Offering ”). Completion... Read More

Calgary, AB – TheNewswire - April 12, 2024 – Universal Ibogaine Inc. ( TSXV:IBO ) (“ UI ” or the “ Company ”), a life sciences company with a mission to research and deliver medicalized ibogaine-centered addiction care, advises that it intends to undertake a non-brokered private placement offering of up to 30,000,000 common shares at a price of $0.02 per share, for proceeds of up to $600,000 (the “ Offering ”). Completion of... Read More

Calgary, AB – TheNewswire - April 10, 2024 – Universal Ibogaine Inc. ( TSXV:IBO ) (“ UI ” or the “ Company ”), a life sciences company with a mission to research and deliver medicalized ibogaine-centered addiction care, is pleased to announce that it has closed its previously announced (see News Release of February 22) non-brokered private placement offering of common shares (the “ Offering ”) and has issued 57,557,600... Read More

Calgary, AB – TheNewswire -- February 22, 2024 – Universal Ibogaine Inc. ( TSXV:IBO ) (“ UI ” or the “ Company ”), a life sciences company with a mission to deliver medicalized ibogaine-centered addiction care, advises that it is undertaking a private placement offering of up to 80,000,000 common shares at a price of $0.01 per share (the “ Offering ”) for proceeds of up to $800,000. The proceeds from the Offering are... Read More

Calgary, AB – TheNewswire - February 7, 2023 – Universal Ibogaine Inc. ( TSXV:IBO ) (“ UI ” or the “ Company ”), a life sciences company with a mission to deliver medicalized ibogaine-centered addiction care, is pleased to announce the closing of its previously announced (see news release of December 20, 2023) non-brokered private placement (the “ Placement ”) of common shares, and has issued 41,719,250 common shares at a... Read More

Calgary, AB – TheNewswire - January 19, 2024 – Universal Ibogaine Inc. ( TSXV:IBO ) (“ UI ” or the “ Company ”), a life sciences company with a mission to deliver medicalized ibogaine-centered addiction care, provides the following bi-weekly default status report update: Further to the Company’s prior news release (January 5, 2024), t he Company is providing this bi-weekly default status report (the “ Default Status Report... Read More

Calgary, AB – TheNewswire -- January 5, 2024 – Universal Ibogaine Inc. ( TSXV:IBO ) (“ UI ” or the “ Company ”), a life sciences company with a mission to deliver medicalized ibogaine-centered addiction care, provides the following bi-weekly default status report update: Further to the Company’s prior news releases (November 20, December 1, December 11, and December 20, 2023), t he Company is providing this bi-weekly default... Read More

Calgary, AB – TheNewswire - December 20, 2023 – Universal Ibogaine Inc. ( TSXV:IBO ) (“ UI ” or the “ Company ”), a life sciences company with a mission to deliver medicalized ibogaine-centered addiction care, provides the following updates: Appointment of new auditors UI advises that MNP LLP (“ MNP ”) have been appointed as auditors of the Company, effective December 6, 2023, commencing with the fiscal year ended July 31,... Read More

Calgary, AB – TheNewswire - December 11, 2023 – Universal Ibogaine Inc. ( TSXV:IBO ) (“ UI ” or the “ Company ”), a life sciences company with a mission to deliver medicalized ibogaine-centered addiction care, advises that its application for a temporary management case trade order (“ MCTO ”) has been granted by the Alberta Securities Commission (the “ ASC ”, as Principal Regulator). UI previously advised (see prior news... Read More

Calgary, AB - TheNewswire - December 1, 2023 - Un iversal Ibogaine Inc. ( TSXV:IBO ) (“ UI ” or the “ Company ”), a life sciences company with a mission to deliver medicalized ibogaine-centered addiction care, advises of the following update and revision to its prior news release which was issued on November 20, 2023. At that time, UI had advised that it has made an application to the Alberta Securities Commission (as... Read More

Calgary, AB - TheNewswire - October 12, 2023 - Universal Ibogaine Inc. ( TSXV:IBO) (“UI” or the “Company ”), a life sciences company with a mission to deliver medicalized ibogaine-centered addiction care, advises of the following changes to its Board of Directors, effective October 11, 2023: UI has appointed two new members to serve on the Company’s Board of Directors (the “ Board ”) to replace two Board members. Chief Ian... Read More

Calgary, AB – TheNewswire - October 4, 2023 – Universal Ibogaine Inc. ( TSXV:IBO ) (“ UI ” or the “ Company ”), a life sciences company with a mission to deliver medicalized ibogaine-centered addiction care, is pleased to advise that it has engaged and retained Mike “Zappy” Zapolin as a strategic and business development advisor. Zappy Zapolin is a well-known USA based futurist, entrepreneur, and award-winning filmmaker who... Read More

Calgary, AB - TheNewswire - September 6 , 2023 - Universal Ibogaine Inc. ( TSXV:IBO ) (“ UI ” or the “ Company ”), a life sciences company with a mission to deliver medicalized ibogaine-centered addiction care, provides the following updates: UI continues efforts to seek to sell its 20 acre undeveloped Belize island property (see prior news release of June 7, 2023) and a further update will be provided as more information... Read More

Calgary, AB – TheNewswire - June 7, 2023 – Universal Ibogaine Inc. ( TSXV:IBO ) (“ UI ” or the “ Company ”), a life sciences company with a mission to deliver medicalized ibogaine-centered addiction care, advises that it will not be closing its previously announced (see News Release of March 30, 2023) agreement to sell its 20-acre undeveloped island property located in Belize (the “ Property ”) for USD 1,300,000 on June 15,... Read More

Calgary, AB – TheNewswire - May 19, 2023 – Universal Ibogaine Inc. ( TSXV:IBO ) (“ UI ” or the “ Company ”), a life sciences company with a mission to deliver medicalized ibogaine-centered addiction care, advises that it is undertaking an offering of up to 66,666,667 share “ Units ” at a price of $0.03 per Unit (the “ Offering ”) for proceeds of up to $2,000,000. Each Unit will consist of one common share and a one-half... Read More

Calgary, AB – TheNewswire - May 9, 2023 – Universal Ibogaine Inc. ( TSXV:IBO ) (“ UI ” or the “ Company ”), a life sciences company with a mission to deliver medicalized ibogaine-centered addiction care, advises of the departure of two members of its Board of Directors (the “ Board ”). Dr. Alberto Sola Agullo has decided to resign from the Board in order to focus his time on his ibogaine based addiction treatment business,... Read More

Calgary, AB – TheNewswire - April 13, 2023 – Universal Ibogaine Inc. ( TSXV:IBO ) (“ UI ” or the “ Company ”), a life sciences company with a mission to deliver medicalized ibogaine-centered addiction care, advises that it has processed a closing of $180,000 under its previously announced (see News Release of March 16, 2023) offering of convertible debt securities (the “ Offering ”). The Offering consisted of “Secured... Read More

Calgary, AB – TheNewswire - March 30, 2023 – Universal Ibogaine Inc. ( TSXV:IBO ) (“ UI ” or the “ Company ”), a life sciences company with a mission to deliver medicalized ibogaine-centered addiction care, advises that it has reached an agreement (the “ Offer ”) to sell its 20-acre undeveloped island property located in Belize (the “ Property ”) for USD 1,300,000. A summary of the terms of the sale transaction follows: The... Read More

Calgary, AB – TheNewswire - February 6, 2023 – Universal Ibogaine Inc. ( TSXV:IBO ) (“ UI ” or the “ Company ”), a life sciences company with a mission to deliver medicalized ibogaine-centered addiction care, advises that it is in process of finalizing an offering of convertible debt securities (the “ Offering ”). The Offering consists of up to $5 million of “Secured Guarantee Convertible Notes” (the “ Notes ”) which will... Read More

Calgary, AB – TheNewswire - January 23, 2023 – Universal Ibogaine Inc. ( TSXV:IBO ) (“ UI ” or the “ Company ”), a life sciences company with a mission to deliver medicalized ibogaine-centered addiction care, advises that it’s addiction and mental health treatment clinic, the Kelburn Recovery Center (“ Kelburn ”), which operates near Winnipeg, Manitoba via a wholly-owned subsidiary of UI, has re-opened effective January 23,... Read More